Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Oct 15, 2026

Reasons to Hold HealthEquity Stock in Your Portfolio for Now

HQY's strong HSA growth, AI-driven efficiencies and raised fiscal 2027 outlook support momentum, though cybersecurity risks remain a concern.

Zacks Investment Research • Oct 7, 2026

HealthEquity: AI Cash Fears Create A 'Buy' Opportunity

HealthEquity stands out as a beneficiary of durable HSA growth and higher-for-longer interest rates, with AI-driven cash-sorting risks seen as overblown. HQY's earnings are poised for material upside as fixed-rate contracts mature, with incremental net interest income tailwinds and strong account growth supporting double-digit EPS growth. Recent financials highlight robust EBITDA margin expansion, conservative leverage near 1x, and active share repurchases, reducing share count by 4% year-over-year.

Seeking Alpha • Oct 2, 2026

HealthEquity Appoints Moody's CFO Noémie Heuland to Board of Directors

DRAPER, Utah, Sept. 30, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced that Noémie Heuland, Chief Financial Officer of Moody's Corporation (NYSE: MCO), has been elected to its board of directors (the “Board”) effective Sept.

GlobeNewsWire • Sep 30, 2026

Here's Why HealthEquity (HQY) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Sep 24, 2026

HQY Up 15.7% in 3 Months as HSA Growth Builds: Can the Rally Continue?

HealthEquity's 15.7% three-month rally is backed by rising HSA scale, stronger margins and higher guidance, though key risks remain.

Zacks Investment Research • Sep 2, 2026

Why HealthEquity Stock Sank This Week

HealthEquity posted significant sales and earnings beats with its fiscal Q2 report. The company issued a small increase for its full-year guidance, but management kept its forecast for adjusted earnings per share the same.

The Motley Fool • Aug 30, 2026

HealthEquity Q2 Earnings Call Highlights

HealthEquity NASDAQ: HQY reported accelerated revenue growth and record profitability in its fiscal 2027 second quarter, citing HSA account expansion, higher member engagement and technology-driven service efficiencies. The company raised its full-year outlook after generating record adjusted EBITDA margin of 48%.

MarketBeat • Aug 27, 2026

HealthEquity, Inc. (HQY) Q2 2027 Earnings Call Transcript

HealthEquity, Inc. (HQY) Q2 2027 Earnings Call Transcript

Seeking Alpha • Aug 27, 2026

HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results

Highlights of the second quarter include: Net income increased 10% to $65.6 million, and net income margin increased to 19% from 18% last year. Adjusted EBITDA increased 11% to $167.0 million, and Adjusted EBITDA margin increased to 48% from 46% last year.

GlobeNewsWire • Aug 27, 2026